The Team
25 years of total C-Level management experience in international businesses, 15 years in healthcare industry Engineering background with MBA and PHD on management and organization Walgreens Boots Alliance-Turkey: CEO / 2005-2013 - Responsible of Turkey, Egypt and Algeria operations, 7 billion USD annual revenue with 13.000 employees, successful exit with a valuation of 1 billion USD Member of Walgreens Boots Alliance European Executive Committee between 2010-2013 BMC Automotive: CEO / 2014-2021, 700 million USD annual revenue with 3.700 employees in 17 countries. Raised financing of 1 billion USD from international banks
30+ years of C-Level management experience PWC: Audit / 1985-1988 Sabanci Holding: Internal Audit Manager / 1988-1990 Istanbul Stock Exchange: CFO, Director of Bond & Bills Department and Futures and Options Department / 1991- 1999 Istanbul Gold Exchange / Istanbul Gold Refinery: Vice Chairman / 1999-2003 BMC Automotive: Group CFO / 2013-2021, 700 million USD annual revenue with 3.700 employees in 17 countries, financing of 1 billion USD
20+ years of experience in drug development with molecular biology, human genetics, cellular and animal models Professor and Head of Medical Biology Department, Facult of Medicine of Atatürk University Currently leading a group of 20 researchers working on in vitro and in vivo disease modelling for efficacy evaluations and toxicology testing in drug discovery and optimization Molecular Biology and Genetics consultant of The Scientific and Technological Research Council of Turkey (TÜBITAK) 2013-Present, General Directorate of Food Control, Turkey, Science Commission Member and Chairman
20 years of private equity investment experience in Europe and Turkey Taxim Capital (Alkima Partners), Istanbul: Founder, Managing Partner, Private Equity Fund / 2015 - ongoing, total fundraising of 250 million USD Pamplona Capital, London: Partner, Founding Team Member, Private Equity Fund / 2006 - 2015, total fundraising of 1,5 billion USD Merrill Lynch, London: Associate, Investment Banking / 2005 - 2006 McKinsey & Company, Istanbul & Dubai: Business Analyst, Management Consulting / 2000 - 2003
30+ years of experience as senior pharma executive and board member with demonstrated achievements in precision medicine and diagnostics Distinguished track record in drug development, companion diagnostics development and commercialization, statistical genetics, pharmacogenomics and translational medicine across multiple therapeutic areas 1999 - 2023: Pfizer Vice President and Head of Diagnostics 2020 - present: Board Member, California Gov's Precision Medicine Advisory Council-USA 2020 - present: Board Member, Progentec Diagnostics-USA 2017-2023: Scientific Co-Chair, Blood Profilling Atlas Commons (Bloodpac)